CDKN2B and neoplasm: We found that CDKN2B‐AS1, YEATS2‐AS1, MIR924HG, SLC16A1‐AS1, LRRC8C‐DT, and LINC01126 expression levels were significantly correlated with clinical stage and tumor grade in EC (Tables S2 and S3).